First of its kind approval for booster vaccination following Sputnik V inoculation

Following approval by the Clinical Trials Committee, the National Medical Taskforce for Combatting the Coronavirus (COVID-19) announced the formal authorisation of Sputnik V as a booster shot for those 18 and above who received their second dose of the Sputnik V vaccine at least six months ago.


The authorisation of the Sputnik V booster shot is the first of its kind globally for individuals who have received the Sputnik V vaccine. 


The decision was taken in line with the latest COVID-19 developments and international best practices as reviewed by the Ministry of Health’s Vaccination Committee, in coordination with the Gamaleya National Research Center of Epidemiology and Microbiology, and Ministry of Health of the Russian Federation. 


Eligible individuals can register for a booster shot by visiting the Ministry of Health’s website on, or via the BeAware application.




Share this page Share on FacebookShare on TwitterShare on Linkedin

Read our latest publication

'Bahrain-France Investor Guide' -
is YOUR guide to invest in Bahrain and in France. Click here to view the online guide